INBX

Inhibrx Biosciences Inc

• TipRanks·33m ago

  Analysts Offer Insights on NA Companies: First Horizon (FHN) and Inhibrx Biosciences Inc (INBX)

• Seeking Alpha·46m ago

  Inhibrx cancer therapy outperforms Merck’s Keytruda in mid-stage trial

• TipRanks·2h ago

  Inhibrx’s INBRX-106 achieves clinical benefit in Phase 2 HNSCC study

• TipRanks·08/24 10:10

  Inhibrx initiated with a Buy at H.C. Wainwright

• Simply Wall St·08/21 21:25

  Inhibrx Biosciences (INBX) Earnings Put Its Valuation Back In Focus

• TipRanks·08/21 10:50

  Analysts Are Bullish on Top NA Stocks: James Hardie Industries PLC (JHX), EMCOR Group (EME)

• Simply Wall St·08/15 23:28

  Should FDA Review of Ozekibart and INBRX-106 Data Milestones Require Action From Inhibrx (INBX) Investors?

• TipRanks·08/14 17:15

  Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained

• TipRanks·08/14 14:05

  Stifel Nicolaus Remains a Buy on Inhibrx Biosciences Inc (INBX)

• Seeking Alpha·08/13 20:42

  Inhibrx Biosciences GAAP EPS of -$2.34 beats by $0.05

• Simply Wall St·07/29 10:16

  Inhibrx Biosciences (INBX) Expands Its Credit Facility, Is The Valuation Risk Priced In?

• Seeking Alpha·07/25 13:36

  Inhibrx Biosciences: The Whole Story Rides On INBRX-106

• Simply Wall St·07/23 02:27

  Does Inhibrx Biosciences' (INBX) Expanded Credit Facility Quietly Redefine Its Risk‑Reward Profile?

• Seeking Alpha·07/17 10:43

  Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act

• TipRanks·07/17 09:17

  Inhibrx Biosciences Expands Credit Facility to $500 Million